Hidradenitis Suppurativa Archives - The Dermatology Digest

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
Hidradenitis Suppurativa Archives - The Dermatology Digest

Incyte’s Povorcitinib Hits Primary Endpoints in Phase 3 HS Studies

Povorcitinib (Incyte) produced statistically significant results for primary endpoints in two Phase 3 Hidradenitis Suppurativa (HS) trials, Incyte reports in a news release.

Category: Hidradenitis Suppurativa

Incyte’s Povorcitinib Hits Primary Endpoints in Phase 3 HS Studies